-Bloomberg TV
Treasury Glut: Can Investor Demand For US Bonds Keep Pace With Supply Increases?
The U.S. Treasury is expected to confirm further increases in government bond supply in its first quarterly refunding announcement of 2024.
Fed’s Mester Says Does See Growth Slowing But Doesn’t Forecast Negative Activity
-Bloomberg TV
Related Posts
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It’s Very Short
The stock market has had a rough going for the first nine months of the year in 2022. All the major indexes are down year-to-date, including the Dow Jones Industrial Average.
Here’s a look at the four stocks in the index that have posted positive gains in 2022.
AstraZeneca And Daiichi Sankyo’s Datopotamab Deruxtecan Extended Progression-Free Survival Vs. Chemotherapy In Patients With HR-Positive, HER2-Low Or Negative Breast Cancer In TROPION-Breast01 Phase III Trial
AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan reduced the risk of disease progression or death by 37%, providing a 2-month median PFS benefit, and was well tolerated in post-endocrine therapy settingPositive
B of A Securities Downgrades Applied Molecular to Underperform, Lowers Price Target to $0.5
B of A Securities analyst Jason Gerberry downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Underperform and lowers the price target from $5 to $0.5.